Notch3 signalling promotes tumour growth in colorectal cancer

Journal of Pathology

Volumn 224, Issue 4, 2011, Pages 448-460

  Serafin, Valentina ^a   Persano, Luca ^a   Moserle, Lidia ^a   Esposito, Giovanni ^b   Ghisi, Margherita ^a   Curtarello, Matteo ^b   Bonanno, Laura ^a   Masiero, Massimo ^a   Ribatti, Domenico ^c   Stürzl, Michael ^d   Naschberger, Elisabeth ^d   Croner, Roland S ^d   Jubb, Adrian M ^e   Harris, Adrian L ^f   Koeppen, Hartmut ^g   Amadori, Alberto ^a,b   Indraccolo, Stefano ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g GENENTECH INC   (United States)

Author keywords

angiogenesis; colorectal cancer; DLL4; Notch3

Indexed keywords

JAGGED1; NOTCH3 RECEPTOR; PROTEIN; RECOMBINANT PROTEIN; SHORT HAIRPIN RNA;

ARTICLE; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLONOGENIC ASSAY; COLORECTAL CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; XENOGRAFT;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 79959952635     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2895     Document Type: Article

References (50)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ,. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-776. (Pubitemid 29291335)
2. Chiba S,. Notch signaling in stem cell systems. Stem Cells 2006; 24: 2437-2447. (Pubitemid 44674304)
3. Gridley T,. Notch signaling in vertebrate development and disease. Mol Cell Neurosci 1997; 9: 103-108. (Pubitemid 27342641)
4. D'Souza B, Miyamoto A, Weinmaster G,. The many facets of Notch ligands. Oncogene 2008; 27: 5148-5167.
5. Hsieh JJ, Henkel T, Salmon P, et al., Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 1996; 16: 952-959. (Pubitemid 26061666)
6. Johnston SH, Rauskolb C, Wilson R, et al., A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 1997; 124: 2245-2254. (Pubitemid 27283245)
7. Kopan R,. Notch: a membrane-bound transcription factor. J Cell Sci 2002; 115: 1095-1097. (Pubitemid 34272474)
8. Ellisen LW, Bird J, West DC, et al., TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649-661. (Pubitemid 121001701)
9. Lee SY, Kumano K, Masuda S, et al., Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia 2005; 19: 1841-1843. (Pubitemid 41486167)
10. Weng AP, Ferrando AA, Lee W, et al., Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-271. (Pubitemid 39336870)
11. Bellavia D, Campese AF, Alesse E, et al., Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 2000; 19: 3337-3348. (Pubitemid 30428211)
12. Miele L, Golde T, Osborne B,. Notch signaling in cancer. Curr Mol Med 2006; 6: 905-918. (Pubitemid 44883940)
13. Park JT, Li M, Nakayama K, et al., Notch3 gene amplification in ovarian cancer. Cancer Res 2006; 66: 6312-6318.
14. Haruki N, Kawaguchi KS, Eichenberger S, et al., Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res 2005; 65: 3555-3561. (Pubitemid 40616330)
15. Westhoff B, Colaluca IN, D'Ario G, et al., Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A 2009; 106: 22293-22298.
16. Pece S, Serresi M, Santolini E, et al., Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004; 167: 215-221. (Pubitemid 39435065)
17. Choi JH, Park JT, Davidson B, et al., Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. Cancer Res 2008; 68: 5716-5723.
18. Sjolund J, Johansson M, Manna S, et al., Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 2008; 118: 217-228.
19. Sansone P, Storci G, Tavolari S, et al., IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007; 117: 3988-4002. (Pubitemid 350224108)
20. Riccio O, van Gijn ME, Bezdek AC, et al., Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. EMBO Rep 2008; 9: 377-383.
21. van Es JH, van Gijn ME, Riccio O, et al., Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435: 959-963. (Pubitemid 40896322)
22. Leow CC, Romero MS, Ross S, et al., Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res 2004; 64: 6050-6057. (Pubitemid 39129403)
23. Augenlicht L, Velcich A, Mariadason J, et al., Colonic cell proliferation, differentiation, and apoptosis. Adv Exp Med Biol 1999; 470: 15-22.
24. Katoh M, Katoh M,. Notch signaling in gastrointestinal tract. Int J Oncol 2007; 30: 247-251.
25. Qiao L, Wong BC,. Role of Notch signaling in colorectal cancer. Carcinogenesis 2009; 30: 1979-1986.
26. Fre S, Pallavi SK, Huyghe M, et al., Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci U S A 2009; 106: 6309-6314.
27. Rodilla V, Villanueva A, Obrador-Hevia A, et al., Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc Natl Acad Sci U S A 2009; 106: 6315-6320.
28. Jubb AM, Turley H, Moeller HC, et al., Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. Br J Cancer 2009; 101: 1749-1757.
29. Reedijk M, Odorcic S, Zhang H, et al., Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol 2008; 33: 1223-1229.
30. Zhang Y, Li B, Ji ZZ, et al., Notch1 regulates the growth of human colon cancers. Cancer 2010; 116: 5207-5218.
31. Indraccolo S, Minuzzo S, Masiero M, et al., Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Cancer Res 2009; 69: 1314-1323.
32. Dalerba P, Guiducci C, Poliani PL, et al., Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Cancer Res 2005; 65: 2321-2329. (Pubitemid 40490142)
33. Naschberger E, Croner RS, Merkel S, et al., Angiostatic immune reaction in colorectal carcinoma: impact on survival and perspectives for antiangiogenic therapy. Int J Cancer 2008; 123: 2120-2129.
34. Joutel A, Andreux F, Gaulis S, et al., The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000; 105: 597-605. (Pubitemid 30146506)
35. Chadwick N, Zeef L, Portillo V, et al., Identification of novel Notch target genes in T cell leukaemia. Mol Cancer 2009; 8: 35.
36. Palomero T, Lim WK, Odom DT, et al., NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 2006; 103: 18261-18266. (Pubitemid 44871646)
37. Williams CK, Li JL, Murga M, et al., Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006; 107: 931-939. (Pubitemid 43156289)
38. Sonoshita M, Aoki M, Fuwa H, et al., Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell 2011; 19: 125-137.
39. Song G, Zhang Y, Wang L,. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 2009; 284: 31921-31927.
40. Wu Y, Cain-Hom C, Choy L, et al., Therapeutic antibody targeting of individual Notch receptors. Nature 2010; 464: 1052-1057.
41. Beatus P, Lundkvist J, Oberg C, et al., The notch 3 intracellular domain represses notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters. Development 1999; 126: 3925-3935. (Pubitemid 29440489)
42. Shimizu K, Chiba S, Saito T, et al., Functional diversity among Notch1, Notch2, and Notch3 receptors. Biochem Biophys Res Commun 2002; 291: 775-779. (Pubitemid 34694342)
43. Yamaguchi N, Oyama T, Ito E, et al., NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 2008; 68: 1881-1888. (Pubitemid 351416574)
44. Meng RD, Shelton CC, Li YM, et al., I-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res 2009; 69: 573-582.
45. Croner RS, Fortsch T, Bruckl WM, et al., Molecular signature for lymphatic metastasis in colorectal carcinomas. Ann Surg 2008; 247: 803-810. (Pubitemid 351591515)
46. Croner RS, Peters A, Brueckl WM, et al., Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma. Cancer 2005; 104: 395-404. (Pubitemid 40993269)
47. Croner RS, Guenther K, Foertsch T, et al., Tissue preparation for gene expression profiling of colorectal carcinoma: three alternatives to laser microdissection with preamplification. J Lab Clin Med 2004; 143: 344-351. (Pubitemid 38859672)
48. Ribatti D, Nico B, Vacca A, et al., The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 2006; 1: 85-91.
49. Indraccolo S, Gola E, Rosato A, et al., Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther 2002; 9: 867-878. (Pubitemid 34716331)
50. Keyaerts M, Verschueren J, Bos TJ, et al., Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-luciferin: effect on intensity, time kinetics and repeatability of photon emission. Eur J Nucl Med Mol Imaging 2008; 35: 999-1007.